Drug Profile
Etanercept biosimilar - Biotrion
Alternative Names: BTD-001-BiotrionLatest Information Update: 17 Nov 2021
Price :
$50
*
At a glance
- Originator Biotrion
- Class Anti-inflammatories; Antipsoriatics; Antirheumatics; Disease-modifying antirheumatics; Recombinant fusion proteins; Skin disorder therapies
- Mechanism of Action Tumour necrosis factor alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Rheumatoid arthritis
Most Recent Events
- 14 May 2015 No development reported for Rheumatoid arthritis in South Korea (SC)
- 01 May 2015 Early research in Rheumatoid arthritis in South Korea (SC)